Sands Lab샌즈랩
411080 · KOSDAQ · ₩411080 · 샌즈랩
₩7,900▼ ₩850 (9.71%)End-of-day · Oct 29, 2026 · End-of-day prices.
Income statement
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩1.5B | ₩1.8B | ₩6.4B | ₩802M | ₩3.7B | ₩714M | ₩4.9B | ₩1.8B |
| Cost of sales | ₩2.4B | ₩2.8B | ₩3.9B | ₩2.3B | ₩5.1B | ₩2.2B | ₩4.8B | ₩2.6B |
| Gross profit | −₩866M | −₩1B | ₩2.5B | −₩1.5B | −₩1.4B | −₩1.4B | ₩114M | −₩820M |
| Operating income | −₩866M | −₩1B | ₩2.5B | −₩1.5B | −₩1.4B | −₩1.4B | ₩114M | −₩820M |
| Net income | −₩1.9B | −₩638M | ₩1.6B | −₩911M | ₩370M | −₩1.5B | ₩161M | −₩686M |
| Net income to shareholders | −₩1.8B | −₩631M | ₩1.5B | −₩911M | ₩407M | −₩1.5B | ₩161M | −₩686M |
Balance sheet
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total assets | ₩53B | ₩53B | ₩58B | ₩56B | ₩57B | ₩57B | ₩50B | ₩54B |
| Current assets | ₩34B | ₩33B | ₩37B | ₩35B | ₩38B | ₩40B | ₩37B | ₩43B |
| Cash and equivalents | ₩4.1B | ₩5.9B | ₩34B | ₩6.7B | ₩9.5B | ₩8.5B | ₩31B | ₩4.1B |
| Total liabilities | ₩3.7B | ₩2B | ₩3.7B | ₩3.3B | ₩3.2B | ₩4.3B | ₩2.7B | ₩6.1B |
| Current liabilities | ₩3.7B | ₩2B | ₩3.7B | ₩3.3B | ₩3.2B | ₩4.3B | ₩2.7B | ₩6.1B |
| Total equity | ₩49B | ₩51B | ₩54B | ₩53B | ₩54B | ₩53B | ₩48B | ₩47B |
| Shareholders' equity | ₩49B | ₩51B | ₩54B | ₩53B | ₩53B | ₩53B | ₩48B | ₩47B |
Cash flow
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | ₩348M | −₩2.1B | ₩3B | −₩207M | −₩1.3B | −₩1.2B | −₩842M | ₩2.8B |
| Capital spending | ₩311M | ₩3.5M | ₩37M | ₩40M | ₩178M | ₩340M | ₩3.9B | ₩1.1B |
| Free cash flow | ₩36M | −₩2.1B | ₩3B | −₩247M | −₩1.5B | −₩1.5B | −₩4.8B | ₩1.7B |
| Dividends paid | ₩0 | ₩2.3B | — | — | — | — | — | — |
Consolidated where available. Amounts in won.
Also known as: Sands Lab / 샌즈랩 / 411080 / KRX:411080
Source: KRX statistical information